Ghent University Academic Bibliography

Journal Article
A1
open access

Assessment of cardiovascular safety of anti-osteoporosis drugs

N. R. Fuggle, C. Cooper, N. C. Harvey, N. Al-Daghri, M. -L. Brandi, O. Bruyere, A. Cano, E. M. Dennison, A. Diez-Perez, Jean Kaufman (UGent) , et al.

(2020) DRUGS. 80(15). p.1537-1552

Add to list

Journal Article
A1
open access

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength : state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Adolfo Diez-Perez, Maria Luisa Brandi, Nasser Al-Daghri, Jaime C. Branco, Olivier Bruyere, Loredana Cavalli, Cyrus Cooper, Bernard Cortet, Bess Dawson-Hughes, Hans Peter Dimai, et al.

(2019) AGING CLINICAL AND EXPERIMENTAL RESEARCH. 31(10). p.1375-1389

Add to list

Journal Article
A1
open access

Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis

Mattias Lorentzon, Jaime Branco, Maria Luisa Brandi, Olivier Bruyere, Roland Chapurlat, Cyrus Cooper, Bernard Cortet, Adolfo Diez-Perez, Serge Ferrari, Andrea Gasparik, et al.

(2019) ADVANCES IN THERAPY. 36(10). p.2811-2824

Add to list

Journal Article
A1
open access

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment : results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)

M. Hiligsmann, D. Cornelissen, B. Vrijens, B. Abrahamsen, N. Al-Daghri, E. Biver, M. L. Brandi, O. Bruyere, N. Burlet, C. Cooper, et al.

(2019) OSTEOPOROSIS INTERNATIONAL. 30(11). p.2155-2165

Add to list

Journal Article
A1
open access

Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density : a randomized, double-blind, phase 2, parallel group study

Michael R McClung, Jacques P Brown, Adolfo Diez-Perez, Heinrich Resch, John Caminis, Paul Meisner, Michael A Bolognese, Stefan Goemaere (UGent) , Henry G Bone, Jose R Zanchetta, et al.

(2018) JOURNAL OF BONE AND MINERAL RESEARCH. 33(8). p.1397-1406

Add to list

Patients' preferences for anti-osteoporosis drug treatment : a cross-European discrete choice experiment

Mickael Hiligsmann, Benedict G Dellaert, Carmen D Dirksen, Verity Watson, Sandrine Bours, Stefan Goemaere (UGent) , Jean-Yves Reginster, Christian Roux, Bernie McGowan, Carmel Silke, et al.

(2017) RHEUMATOLOGY. 56(7). p.1167-1176

Add to list

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data: an expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Cyrus Cooper, Thomas Bardin, Maria-Luisa Brandi, Patrice Cacoub, John Caminis, Roberto Civitelli, Maurizio Cutolo, Willard Dere, Jean-Pierre Devogelaer, Adolfo Diez-Perez, et al.

(2016) AGING CLINICAL AND EXPERIMENTAL RESEARCH. 28(1). p.1-16

Add to list

Treatment of osteoporosis in men

Jean Kaufman (UGent) , J-Y Reginster, S Boonen, ML Brandi, C Cooper, W Dere, J-P Devogelaer, A Diez-Perez, JA Kanis, E McCloskey, et al.

(2013) BONE. 53(1). p.134-144

Add to list

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis

René Rizzoli, Jean-Yves Reginster, Steven Boonen, Gérard Bréart, Adolfo Diez-Perez, Dieter Felsenberg, Jean Kaufman (UGent) , John A Kanis and Cyrus Cooper

(2011) CALCIFIED TISSUE INTERNATIONAL. 89(2). p.91-104

Add to list

Miscellaneous

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

JY REGINSTER, E ABADIE, P DELMAS, R RIZZOLI, W DERE, P DER AUWERA, B AVOUAC, ML BRANDI, A DAIFOTIS, A DIEZ-PEREZ, et al.

(2006) OSTEOPOROSIS INTERNATIONAL. 17(1). p.1-7

Academic Bibliography

Assessment of cardiovascular safety of anti-osteoporosis drugs

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength : state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis

Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density : a randomized, double-blind, phase 2, parallel group study

Patients' preferences for anti-osteoporosis drug treatment : a cross-European discrete choice experiment

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data: an expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Treatment of osteoporosis in men

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

Contents

Support

Contact